Recipharm to buy remaining stake in Nitin Lifesciences

This article was originally published here

Recipharm has agreed to acquire the remaining 26% stake in Nitin Lifesciences, which were owned by members of the founding Sobti family.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply